Publicaciones (16) Publicaciones de LARRAITZ EGAÑA OTAÑO

2022

  1. Author Correction: PR-LncRNA signature regulates glioma cell activity through expression of SOX factors (Scientific Reports, (2018), 8, 1, (12746), 10.1038/s41598-018-30836-5)

    Scientific Reports

2021

  1. Identification of a dexamethasone mediated radioprotection mechanism reveals new therapeutic vulnerabilities in glioblastoma

    Cancers, Vol. 13, Núm. 2, pp. 1-23

  2. SEOM clinical guideline for management of adult medulloblastoma (2020)

    Clinical and Translational Oncology, Vol. 23, Núm. 5, pp. 940-947

2020

  1. Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Liquid biopsy in glioblastoma: Opportunities, applications and challenges

    Cancers, Vol. 11, Núm. 7

2018

  1. Indirect costs associated with glioblastoma: Experience at one hospital

    Neurologia, Vol. 33, Núm. 2, pp. 121-128

  2. PR-LncRNA signature regulates glioma cell activity through expression of SOX factors

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Oncogenic activity of SOX1 in glioblastoma

    Scientific Reports, Vol. 7

2016

  1. SOX9-regulated cell plasticity in colorectal metastasis is attenuated by rapamycin

    Scientific Reports, Vol. 6

  2. Targeting SOX2 as a therapeutic strategy in glioblastoma

    Frontiers in Oncology

2012

  1. Funciones y organización de un comité de neurooncologí a en un hospital con servicio de neurocirugía

    Neurocirugia, Vol. 23, Núm. 4, pp. 151-156

2007

  1. Coriocarcinoma: importancia del diagnóstico precoz

    Ciencia ginecológika, Núm. 1, pp. 53-54

2004

  1. Un caso de melanoma maligno meníngeo en un varón adulto que debuta con paraplejia

    Oncologia, Vol. 27, Núm. 9, pp. 47-51

2003

  1. Fibromatosis agresiva en un varón adolescente

    Revista de oncología: Publicación oficial de la Federación de Sociedades Españolas de Oncología y del Instituto Nacional de Cancerología de México, Vol. 5, Núm. 2, pp. 111-112

2001

  1. Nasopharyngeal myasis by third stage larvae of Oestrus ovis

    Enfermedades infecciosas y microbiología clínica

1999

  1. Phase II clinical trial of cisplatin, 5-fluorouracil, and ifosfamide as treatment for advanced locoregional head and neck carcinoma

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 22, Núm. 1, pp. 6-7